Evidence map›Paper›PMID 35041299›Full record

ArticleJournal of extracellular vesicles2022

Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment.

Senlin Zhao, Yushuai Mi, Binbin Zheng, Ping Wei, Yanzi Gu, Zhengxiang Zhang, Ye Xu, Sanjun Cai, Xinxiang Li, Dawei Li

Open access · goldAbstract read
In one paragraph

Article in Journal of extracellular vesicles, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 151 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
151citing papers in PubMed, 2 pooled it
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

151 citing papers in PubMed, 2 syntheses or guidelines pooled it, 207 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Targeting FAPActa pharmaceutica Sinica. B · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

91 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Senlin ZhaoDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Yushuai MiDepartment of Gastrointestinal Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Binbin ZhengDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Ping WeiDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Yanzi GuDepartment of Biobank, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhengxiang ZhangDepartment of Oncology, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China.
Ye XuDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Sanjun CaiDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Xinxiang LiDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Dawei LiDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Fudan University Shanghai Cancer Center · CNShanghai Medical College of Fudan University · CNFirst Affiliated Hospital of Wannan Medical College · CNSecond Hospital of Shandong University · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver metastasis of colorectal cancer (CRLM) is the most common cause of CRC-related mortality, and is typically caused by interactions between CRC cells and the tumour microenvironment (TME) in the liver. However, the molecular mechanisms underlying the crosstalk between tumour-derived extracellular vesicle (EV) miRNAs and the TME in CRLM have yet to be fully elucidated. The present study demonstrated that highly metastatic CRC cells released more miR-181a-5p-rich EVs than cells which exhibit a low metastatic potential, in-turn promoting CRLM. Additionally, we verified that FUS mediated packaging of miR-181a-5p into CRC EVs, which in-turn persistently activated hepatic stellate cells (HSCs) by targeting SOCS3 and activating the IL6/STAT3 signalling pathway. Activated HSCs could secrete the chemokine CCL20 and further activate a CCL20/CCR6/ERK1/2/Elk-1/miR-181a-5p positive feedback loop, resulting in reprogramming of the TME and the formation of pre-metastatic niches in CRLM. Clinically, high levels of serum EV containing miR-181a-5p was positively correlated with liver metastasis in CRC patients. Taken together, highly metastatic CRC cells-derived EVs rich in miR-181a-5p could activate HSCs and remodel the TME, thereby facilitating liver metastasis in CRC patients. These results provide novel insight into the mechanism underlying liver metastasis in CRC.

Indexed as

Tumor MicroenvironmentBiomarkers, TumorChemokine CCL20Colorectal Neoplasmsets-Domain Protein Elk-1Extracellular VesiclesFeedback, PhysiologicalHepatic Stellate CellsHumansInterleukin-6LiverLiver NeoplasmsMicroRNAsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Receptors, CCR6Biomarkers, TumorCCL20 protein, humanCCR6 protein, humanChemokine CCL20ELK1 protein, humanets-Domain Protein Elk-1FUS protein, humanIL6 protein, humanInterleukin-6MAPK1 protein, humanMAPK3 protein, humanMicroRNAsMIrn181 microRNA, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Receptors, CCR6RNA-Binding Protein FUSSOCS3 protein, humanSTAT3 protein, humanSTAT3 Transcription FactorSuppressor of Cytokine Signaling 3 ProteinCCL20/CCR6/ERK1/2/Elk-1/miR-181a-5p feedback loopcolorectal liver metastasisextracellular vesiclehepatic stellate cellmiR-181a-5ptumour microenvironment

Identifiers

PMID35041299
PMCPMC8765330
OpenAlexW4206125279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.